The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome: Results of a Prospective Multicenter Study
Open accessAbstract
Background and Purpose— Early hemorrhagic transformation (HT) is a complication of ischemic stroke but its effect on patient outcome is unclear. The aims of this study were to assess: (1) the rate of early HT in patients admitted for ischemic stroke, (2) the correlation between early HT and functional outcome at 3 months, and (3) the risk factors for early HT. Methods— Consecutive patients with ischemic stroke were included in this prospective study in 4 study centers. Early HT was assessed by CT examination performed at day 5±2 after stroke onset. Study outcomes were 3-month mortality or disability. Disability was assessed using a modified Rankin score (≥3 indicating disabling stroke) by neurologists unaware of the occurrence of HT in the individual cases. Outcomes in patients with and without early HT were compared by χ 2 test. Multiple logistic regression analysis was used to identify predictors for HT. Results— Among 1125 consecutive patients (median age 76.00 years), 98 (8.7%) had HT, 62 (5.5%) had hemorrhagic infarction, and 36 (3.2%) parenchymal hematoma. At 3 months, 455 patients (40.7%) were disabled or died. Death or disability was seen in 33 patients with parenchymal hematoma (91.7%), in 35 patients with hemorrhagic infarction (57.4%) as compared with 387 of the 1021 patients without HT (37.9%). At logistic regression analysis, parenchymal hematoma, but not hemorrhagic infarction, was independently associated with an increased risk for death or disability (OR 15.29; 95% CI 2.35 to 99.35). At logistic regression analysis, parenchymal hematoma was predicted by large lesions (OR 12.20, 95% CI 5.58 to 26.67), stroke attributable to cardioembolism (OR 5.25; 95% CI 2.27 to 12.14) or to other causes (OR 6.77; 95% CI 1.75 to 26.18), high levels of blood glucose (OR 1.01; 95% CI 1.00 to 1.01), and thrombolytic treatment (OR 3.54, 95% CI 1.04 to 11.95). Conclusions— Early HT occurs in about 9% of patients. Parenchymal hematoma, seen in about 3% of patients, is associated with an adverse outcome. Parenchymal hematoma was predicted by large lesions attributable to cardioembolism or other causes, high blood glucose, and treatment with thrombolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
Larrue, V., von Kummer, R., Müller, A., & Bluhmki, E. (2001) · Stroke · doi:10.1161/01.str.32.2.438 · Cited by 1,006
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Arterial territories of the human brain: Cerebral hemispheres
Tatu, L., Moulin, T., Bogousslavsky, J., & Duvernoy, H. (1998) · Neurology · doi:10.1212/wnl.50.6.1699 · Cited by 614
Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic?
Berger, C., Fiorelli, M., Steiner, T., Schäbitz, W.-R., Bozzao, L., Bluhmki, E., Hacke, W., & von Kummer, R. (2001) · Stroke · doi:10.1161/01.str.32.6.1330 · Cited by 552
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Arterial territories of human brain: Brainstem and cerebellum
Tatu, L., Moulin, T., Bogousslavsky, J., & Duvernoy, H. (1996) · Neurology · doi:10.1212/wnl.47.5.1125 · Cited by 465
The Clinical Meaning of Rankin ‘Handicap’ Grades After Stroke
de Haan, R., Limburg, M., Bossuyt, P., van der Meulen, J., & Aaronson, N. (1995) · Stroke · doi:10.1161/01.str.26.11.2027 · Cited by 457
Wolpert, S. M., Brückmann, H., Greenlee, R. G., Wechsler, L. R., Pessin, M. S., & del Zoppo, G. J. (1993) · PubMed Central · Cited by 415
Hemorrhagic cerebral infarction--a prospective study.
Hornig, C. R., Dorndorf, W., & Agnoli, A. L. (1986) · Stroke · doi:10.1161/01.str.17.2.179 · Cited by 333
Hemorrhagic transformation in cerebral embolism.
Okada, Y., Yamaguchi, T., Minematsu, K., Miyashita, T., Sawada, T., D, S. S. M., Fujishima, M., & Omae, T. (1989) · Stroke · doi:10.1161/01.str.20.5.598 · Cited by 305
Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Trouillas, P., & von Kummer, R. (2006) · Stroke · doi:10.1161/01.str.0000196942.84707.71 · Cited by 260
Hemorrhagic Transformation in Acute Ischemic Stroke: The MAST-E Study
Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
Toni, D., Fiorelli, M., Bastianello, S., Sacchetti, M. L., Sette, G., Argentino, C., Montinaro, E., & Bozzao, L. (1996) · Neurology · doi:10.1212/wnl.46.2.341 · Cited by 205
Neumann-Haefelin, T., Hoelig, S., Berkefeld, J., Fiehler, J., Gass, A., Humpich, M., Kastrup, A., Kucinski, T., Lecei, O., Liebeskind, D. S., et al. (2006) · Stroke · doi:10.1161/01.str.0000239321.53203.ea · Cited by 200
Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke
Lansberg, M. G., Thijs, V. N., Bammer, R., Kemp, S., Wijman, C. A. C., Marks, M. P., & Albers, G. W. (2007) · Stroke · doi:10.1161/strokeaha.106.480475 · Cited by 199
Dzialowski, I., Pexman, J. H. W., Barber, P. A., Demchuk, A. M., Buchan, A. M., & Hill, M. D. (2007) · Stroke · doi:10.1161/01.str.0000251644.76546.62 · Cited by 189
Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence.
Lyden, P. D., & Zivin, J. A. (1993) · PubMed · Cited by 162
Thrombolytic Agents in the Treatment of Stroke
Pessin, M. S., del Zoppo, G. J., & Estol, C. J. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199008000-00001 · Cited by 136
Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke
Palumbo, V., Boulanger, J.-M., Hill, M. D., Inzitari, D., & Buchan, A. M. (2007) · Neurology · doi:10.1212/01.wnl.0000257817.29883.48 · Cited by 132
Hemorrhage After Thrombolytic Therapy for Stroke
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.487009 · Cited by 130
Alexandrov, A. V., Black, S. E., Ehrlich, L. E., Caldwell, C. B., & Norris, J. W. (1997) · Stroke · doi:10.1161/01.str.28.6.1198 · Cited by 129
Hemorrhagic transformation in cardioembolic cerebral infarction.
Hornig, C. R., Bauer, T., Simon, C., Trittmacher, S., & Dorndorf, W. (1993) · Stroke · doi:10.1161/01.str.24.3.465 · Cited by 114
The clinical spectrum of hemorrhagic infarction.
Ott, B. R., Zamani, A. A., Kleefield, J., et al. (1986) · Stroke · doi:10.1161/01.str.17.4.630 · Cited by 95
Gilligan, A. K., Markus, R., Read, S. J., et al. (2002) · Stroke · doi:10.1161/01.str.0000027859.59415.66 · Cited by 91
Lodder, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00833.x · Cited by 82
Moulin, T., Crépin-Leblond, T., Chopard, J.-L., et al. (2008) · European Neurology · doi:10.1159/000117012 · Cited by 75
Hemorrhage After an Acute Ischemic Stroke
Motto, C., Ciccone, A., Aritzu, E., et al. (1999) · Stroke · doi:10.1161/01.str.30.4.761 · Cited by 69
Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison
Kerényi, L., Kardos, L., Szász, J. A., Szatmári, S., Bereczki, D., Hegedüs, K., & Csiba, L. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01489.x · Cited by 65
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Andrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans
Jickling, G. C., Liu, D., Stamova, B., Ander, B. P., Zhan, X., Lu, A., & Sharp, F. R. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.203 · Cited by 547
Metadata
- Authors
- Paciaroni, M., Agnelli, G., Corea, F., Ageno, W., Alberti, A., Lanari, A., Caso, V., Micheli, S., Bertolani, L., Venti, M., Palmerini, F., Biagini, S., Comi, G., Previdi, P., & Silvestrelli, G.
- Venue
- Stroke
- Published
- 2008-08
- Volume
- 39
- Issue
- 8
- Pages
- 2249-2256
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1968737649
- Cited by
- 507
- References
- 32
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.